Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Koji Hayasaka"'
Autor:
Naohiro Miyashita, Masahiro Onozawa, Shota Yokoyama, Daisuke Hidaka, Koji Hayasaka, Shinji Kunishima, Takanori Teshima
Publikováno v:
HemaSphere, Vol 3, Iss 4 (2019)
Abstract. We retrospectively evaluated 48 essential thrombocythemia (ET) patients who were treated in our institute (male/female, 14/34, median age, 61.5 years). In 14 patients treated with anagrelide (ANA), the degree of platelet count reduction (me
Externí odkaz:
https://doaj.org/article/b81ea8538b294ed8900ff0fe19824587
Autor:
Aika Miya, Akinobu Nakamura, Hideaki Miyoshi, Yoshinari Takano, Kana Sunagoya, Koji Hayasaka, Chikara Shimizu, Yasuo Terauchi, Tatsuya Atsumi
Publikováno v:
Frontiers in Endocrinology, Vol 9 (2018)
ObjectiveThe aim of this study was to examine the fluctuations in CD4+ T cells, CD8+ T cells, and natural CD4+CD25+FoxP3+T-regulatory (Treg) cells following an oral glucose tolerance test (OGTT) in participants with and those without type 2 diabetes
Externí odkaz:
https://doaj.org/article/f84710b469744beb832af81209bd5ead
Autor:
Hiroaki Iijima, Masahiro Onozawa, Eiko Hayase, Junichi Sugita, Kana Sunagoya, Satoshi Yamamoto, Kaoru Kahata, Chikara Shimizu, Ikuko Kagawa, Rie Michimata, Katsuya Fujimoto, Daisuke Hidaka, Hideki Goto, Koji Hayasaka, Takanori Teshima, Tomoyuki Endo, Daigo Hashimoto, Kohei Okada, Souichi Shiratori
Publikováno v:
Journal of Clinical Apheresis. 35:413-419
Background Pegfilgrastim has equivalent efficacy to daily granulocyte colony-stimulating factor (G-CSF) in enhancing neutrophil recovery after chemotherapy, but data on its use for peripheral blood stem cell (PBSC) mobilization are limited. We evalua
Autor:
Ryo Uozumi, Yuya Masuda, Junichi Sugita, Mutsumi Nishida, Chiaki Watanabe, Takayo Sakurazawa, Shuichiro Takahashi, Koji Hayasaka, Takanori Teshima, Makoto Ito
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 66:31-35
Autor:
Ying Taur, Lauren Bohannon, Sean M. Devlin, Daniela Weber, M. A. Jamal, Koji Hayasaka, Melissa D. Docampo, Emily Fontana, D. Pham, Nelson J. Chao, Daigo Hashimoto, Jonathan U. Peled, R. Pinedo, Meagan V. Lew, Joao B. Xavier, Eric G. Pamer, C. Scheid, Anna Staffas, C. K. Stein-Thoeringer, Sergio Giralt, D. Bajic, Molly Maloy, Luigi A Amoretti, G. Armijo, Yusuke Shono, Anthony D. Sung, A. Lazrak, Yuta Hasegawa, Roberta J. Wright, Alessandro Pastore, M. Burgos da Silva, A. Tsakmaklis, J. B. Slingerland, Robert R. Jenq, Ernst Holler, M. E. Arcila, Doris M. Ponce, Kate A. Markey, Annelie Clurman, Julia A. Messina, Antonio L.C. Gomes, Ann E. Slingerland, Eric R. Littmann, M.R.M. van den Brink, Amy Bush, Sebastien Monette, Miguel-Angel Perales, Takanori Teshima, Amanda J. Pickard, Kristi Romero, M. J. G. T. Vehreschild, K. B. Nichols, Justin R. Cross
Publikováno v:
Science
Lactose can fuel GVHD Allogeneic hematopoietic cell transplantation (allo-HCT) is used to treat certain hematopoietic malignancies, but patients have a risk of developing graft-versus-host disease (GVHD). Stein-Thoeringer et al. performed a large-sca
Autor:
Shigeki Hikasa, Ritsuko Kitano, Naoki Takao, Hitoshi Iwabuki, Atsushi Kato, Atsushi Asano, Koji Hayasaka, Kazuya Nagata
Publikováno v:
Seikei-Kakou. 31:243-250
Autor:
Naohiro Miyashita, Ryo Uozumi, Chiaki Watanabe, Syuichiro Takahashi, Yasuhiro Hayashi, Takanori Teshima, Hideki Goto, Masahiro Onozawa, Souichi Shiratori, Kaoru Kahata, Daigo Hashimoto, Makoto Ito, Junichi Sugita, Koji Akizawa, Takayo Uwatoko, Yuko Mogi, Eiko Hayase, Koji Hayasaka, Norihiro Sato
Publikováno v:
Japanese Journal of Transfusion and Cell Therapy. 64:742-751
Autor:
Ohsuke Migita, Daigo Hashimoto, Naohiro Miyashita, Hideki Goto, Kohei Okada, Masahiro Onozawa, Shinji Kunishima, Koji Hayasaka, Takeshi Kondo, Takanori Teshima, Kenichiro Hata, Masao Nakagawa, Takahiro Yamada, Kaoru Kahata
Publikováno v:
Annals of Hematology. 97:629-640
We identified a novel heterozygous ITGB3 p.T720del mutation in a pedigree with macrothrombocytopenia exhibiting aggregation dysfunction. Platelet aggregation induced by ADP and collagen was significantly reduced, while ristocetin aggregation was norm
Autor:
Shota Yokoyama, Masahiro Onozawa, Daisuke Hidaka, Takanori Teshima, Naohiro Miyashita, Shinji Kunishima, Koji Hayasaka
Publikováno v:
HemaSphere, Vol 3, Iss 4 (2019)
HemaSphere
HemaSphere
Supplemental Digital Content is available in the text
We retrospectively evaluated 48 essential thrombocythemia (ET) patients who were treated in our institute (male/female, 14/34, median age, 61.5 years). In 14 patients treated with anagrelide
We retrospectively evaluated 48 essential thrombocythemia (ET) patients who were treated in our institute (male/female, 14/34, median age, 61.5 years). In 14 patients treated with anagrelide
Autor:
Yoshinari Takano, Akinobu Nakamura, Hideaki Miyoshi, Aika Miya, Tatsuya Atsumi, Kana Sunagoya, Yasuo Terauchi, Koji Hayasaka, Chikara Shimizu
Publikováno v:
Frontiers in Endocrinology, Vol 9 (2018)
Objective: The aim of this study was to examine the fluctuations in CD4+ T cells, CD8+ T cells, and natural CD4+CD25+FoxP3+T-regulatory (Treg) cells following an oral glucose tolerance test (OGTT) in participants with and those without type 2 diabete